The ProAir® HFA support library
We want to help you give patients the best care possible. ProAir HFA support is always here
to help you teach patients about asthma, exercise-induced bronchospasm (EIB), chronic
obstructive pulmonary disease (COPD), and how ProAir HFA can help. Look into the resources
Learn more about the etiology, diagnosis, and treatment of asthma with our
Asthma is a chronic inflammatory disorder of the lungs and has many triggers.1
It is characterized by airflow limitation due to airway inflammation, airway
narrowing, and mucus hypersecretion.1 Triggers include tobacco smoke, dust mites,
molds, pollen, pet dander, viruses, exercise, and anxiety.1
Key recommendations from the National Asthma Education and Prevention Program
Guidelines for the Diagnosis and Management of Asthma1:
- Medical history and physical examination to determine whether
episodes of airway obstruction are present
- In patients 5 years or older, determine whether airway obstruction
is reversible by performing spirometry before and after use of a
short-acting beta2-agonist (SABA)
- Develop a written asthma action plan
- Patients who have symptoms more than twice a week during the day,
other than for EIB, or who use more than one 200-puff SABA inhaler per
month may require a long-term controller medication for asthma management
- National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the
Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; October 2007.
Find out about the incidence, diagnosis, and treatment of exercise-induced bronchospasm with our
Exercise-induced bronchospasm—or EIB—is found in up to 90% of patients with
diagnosed asthma and in 5% to 20% of people without known asthma.1,2
Although EIB and asthma share some common symptoms, they are not the same
condition.3,4 Asthma is a chronic inflammatory disorder; EIB is a
temporary condition marked by short-lived episodes of airway obstruction
triggered when moisture and temperature changes cause the airways to become
constricted during or after exercise.3,5
Exercise-induced bronchospasm treatment
- The National Asthma Education and Prevention Program guidelines for
management of EIB recommend prevention and treatment with a short-acting
dose 15 to 30 minutes before exercise3,6
Treat with a SABA
as episodes occur3
- Encourage patients to warm up before exercise and to cover their mouths
with a mask or scarf in cold weather3
- Symptoms may also be the result of poorly controlled persistent asthma;
consider long-term controller therapy3
- Weiler JM, Anderson SD, Randolph C, et al. Pathogenesis, prevalence, diagnosis,
and management of exercise-induced bronchoconstriction: a practice parameter. Ann
Allergy Asthma Immunol. 2010;105:S1-S47.
- Rakkhong K, Kamchaisatian W, Vilaiyuk S, et al. Exercise-induced bronchoconstriction
in rhinitis children without asthma. Asian Pac J Allergy Immunol. 2011;29(3):278-S83.
- National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for
the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health;
- Kukafka DS, Lang DM, Porter S, et al. Exercise-induced bronchospasm in high school athletes
via a free running test. Chest. 1998;114(6):1613-1622.
- Milgrom H, Taussig LM. Keeping children with exercise-induced asthma active. Pediatrics.
- ProAir HFA Prescribing Information. Horsham, PA: Teva Respiratory, LLC; June 2016.
Learn about the diagnosis, management, and prevention of chronic obstructive pulmonary disease with our
Guidelines for the diagnosis, management, and prevention of chronic obstructive
pulmonary disease (COPD) are available from the Global Initiative for Chronic
Obstructive Lung Disease.1 Below are a few of the key recommendations.
How is COPD diagnosed?
- Consider in patients with dyspnea, chronic cough or sputum production, and a
history of exposure to:
- Confirm diagnosis by performing spirometry
- Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis,
Management, and Prevention of Chronic Obstructive Pulmonary Disease. Bethesda, MD: National
Institutes of Health/World Health Organization; 2014.
Teva Cares Foundation Patient Assistance Program
Teva Respiratory is committed to providing patients with high-quality medicines
for asthma, COPD, and EIB. Your patient may qualify for assistance from the
Teva Cares Foundation if you meet the conditions below.
To qualify for assistance from this program, patients must:
- Be a resident of the United States, Puerto Rico, or the US Virgin Islands.
- Not be eligible for any prescription drug benefits through any private or public
- Have a total family annual income of 300% or below the federal poverty level for
- Have a prescription for one or more of the Teva medicines listed on the application.
- Patients will be notified by mail of program acceptance or denial
- If the patient is approved, you will receive a form to complete and return
- Medicine(s) will be shipped to your office directly from the Teva pharmacy
- Once approved, patients are eligible to receive assistance for up to 12 months
- Renewals will be handled on a per-patient basis
Questions? Please call the Teva Cares Foundation toll free at 1-877-237-4881.
The ProAir® HFA Video Library
Some patients learn better from watching videos. See if your patients could benefit from watching
The ProAir® HFA information series:
Using and Cleaning Your ProAir® HFA Inhaler
Getting the Most From Your ProAir® HFA Inhaler